Biotech Values

[whatisthecolorofmone]

Hedge Funds-News: RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech

http://www.insidermonkey.com/blog/ra-capital-is-expecting-a-breakthrough-cancer-drug-from-this-biotech-357181/#6xl7GTtY07BXA50h.99

RA Capital initiated a stake in Dynavax Technologies Corporation (NASDAQ:DVAX) during the first quarter by acquiring about 8.87% of the company’s outstanding stock, amounting to 2.6 million shares valued at $58.32 million. The stock price of the $643.50 million company that develops vaccines and therapeutics using toll-like receptor (TLR) biology has appreciated by more than 32% so far this year. Smart money poured into Dynavax Technologies Corporation (NASDAQ:DVAX) during the first three months of the year as 20 funds had an aggregate investment of $257.52 million in the company at the end of March as compared with 11 firms with $108.78 million in shares at the end of the previous quarter. Aside from RA Capital, Paul Orlin and Alex Porter’s Amici Capital is the largest stockholder of Dynavax Technologies Corporation (NASDAQ:DVAX) among these, holding some 2.47 million shares valued at $55.51 million.

More positive coverage. And no I don't think these guys took their profits on the pop March. They were adding and are holding for a much bigger prize